1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Diabetic Hypertension Global Clinical Trials Review, H2, 2014

Diabetic Hypertension Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Diabetic Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Diabetic Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diabetic Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Diabetic Hypertension Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Diabetic Hypertension 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Diabetic Hypertension to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Diabetic Hypertension to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Diabetic Hypertension 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Diabetic Hypertension Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Troikaa Pharmaceuticals Ltd. 31
Clinical Trial Overview of Troikaa Pharmaceuticals Ltd. 31
Sanofi 32
Clinical Trial Overview of Sanofi 32
Novartis AG 33
Clinical Trial Overview of Novartis AG 33
Clinical Trial Overview of Top Institutes / Government 34
Jikei University School of Medicine 34
Clinical Trial Overview of Jikei University School of Medicine 34
Juntendo University School of Medicine 35
Clinical Trial Overview of Juntendo University School of Medicine 35
Graduate School of Medicine and Faculty of Medicine, The University of Tokyo 36
Clinical Trial Overview of Graduate School of Medicine and Faculty of Medicine, The University of Tokyo 36
Hospital Universitario Pedro Ernesto 37
Clinical Trial Overview of Hospital Universitario Pedro Ernesto 37
Saitama Medical University 38
Clinical Trial Overview of Saitama Medical University 38
Juntendo University 39
Clinical Trial Overview of Juntendo University 39
Osaka University 40
Clinical Trial Overview of Osaka University 40
University of Pavia 41
Clinical Trial Overview of University of Pavia 41
University of Southern Denmark 42
Clinical Trial Overview of University of Southern Denmark 42
Medical University of Vienna 43
Clinical Trial Overview of Medical University of Vienna 43
Five Key Clinical Profiles 44
Appendix 60
Abbreviations 60
Definitions 60
Research Methodology 61
Secondary Research 61
About GlobalData 62
Contact Us 62
Disclaimer 62
Source 62

List of Tables
Diabetic Hypertension Therapeutics, Global, Clinical Trials by Region, 2014* 7
Diabetic Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Diabetic Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Diabetic Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Diabetic Hypertension Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Diabetic Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Diabetic Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Diabetic Hypertension Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Diabetic Hypertension to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Diabetic Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Diabetic Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Diabetic Hypertension to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Diabetic Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Diabetic Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Diabetic Hypertension Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Diabetic Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Diabetic Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Diabetic Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Diabetic Hypertension Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Diabetic Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Diabetic Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Diabetic Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Diabetic Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Diabetic Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Troikaa Pharmaceuticals Ltd., 2014* 31
Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 32
Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 33
Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Jikei University School of Medicine, 2014* 34
Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2014* 35
Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, 2014* 36
Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitario Pedro Ernesto, 2014* 37
Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2014* 38
Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University, 2014* 39
Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2014* 40
Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pavia, 2014* 41
Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Southern Denmark, 2014* 42
Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 43

List of Figures
Diabetic Hypertension Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Diabetic Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Diabetic Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Diabetic Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Diabetic Hypertension Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 11
Proportion of Diabetic Hypertension to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Diabetic Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Diabetic Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Diabetic Hypertension to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Diabetic Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Diabetic Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Diabetic Hypertension Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Diabetic Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Diabetic Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Diabetic Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Diabetic Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Diabetic Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Diabetic Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Diabetic Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Diabetic Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 61

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.